InvestorsHub Logo
Followers 15
Posts 1318
Boards Moderated 0
Alias Born 07/27/2015

Re: plexrec post# 282661

Wednesday, 11/11/2020 7:09:51 PM

Wednesday, November 11, 2020 7:09:51 PM

Post# of 462869
Curious if THAT is why BIIB brought aducanumab back from the dead. It failed in March 2019. Hampel got hired by Eisai in May 2019. aducanumab mysteriously returns from the dead October 2019.

So could Eisai be ready to partner now that they’ve been fooled twice? Or will it take 3 times before they are through with BIIB and it’s lies and start looking for “new” potential for CNS diseases.

Dr. Hampel: sir, I’ve been on board with Anavex and we should take a serious look at Anavex.

Pop the champagne

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News